Great genotypic and phenotypic diversities associated with copy-number variations of complement C4 and RP-C4-CYP21-TNX (RCCX) modules: A comparison of Asian-Indian and European American populations

Molecular Immunology

Volumn 46, Issue 7, 2009, Pages 1289-1303

  Saxena, Kapil ^a   Kitzmiller, Kathryn J ^a,b   Wu, Yee Ling ^a,b   Zhou, Bi ^a   Esack, Nazreen ^a   Hiremath, Leena ^b   Chung, Erwin K ^a,b   Yang, Yan ^a,b   Yu, C Yung ^a,b  

^a NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

CNV; Complement C4A and C4B; Congenital adrenal hyperplasia; Extracellular matrix protein tenascin X; Graft rejections and C4 polymorphisms; Recombinations; Steroid CYP21 hydroxylase; Systemic lupus erythematosus

Indexed keywords

COMPLEMENT COMPONENT C4; COMPLEMENT COMPONENT C4A; COMPLEMENT COMPONENT C4B; HLA DR ANTIGEN; STEROID 21 MONOOXYGENASE;

ADULT; ARTICLE; ASIAN; AUTOIMMUNE DISEASE; C4A GENE; C4B GENE; COMPARATIVE STUDY; CYP21A GENE; CYP21B GENE; EUROPEAN AMERICAN; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCATION; GENETIC RECOMBINATION; GENETIC VARIABILITY; GENOTYPE PHENOTYPE CORRELATION; HAPLOTYPE; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INDIAN; MAJOR HISTOCOMPATIBILITY COMPLEX; NORMAL HUMAN; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RECOMBINANT GENE; RISK FACTOR; RP C4 CYP21 TNX GENE; TNXA GENE;

ASIAN AMERICANS; AUTOIMMUNE DISEASES; COMPLEMENT C4; EUROPEAN CONTINENTAL ANCESTRY GROUP; EYE PROTEINS; GENE DOSAGE; GENE FREQUENCY; GENETIC DISEASES, INBORN; GENETIC VARIATION; GENOTYPE; HLA-DR1 ANTIGEN; HUMANS; INDIA; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; LINKAGE DISEQUILIBRIUM; MEMBRANE PROTEINS; PHENOTYPE; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; STEROID 21-HYDROXYLASE; TENASCIN; UNITED STATES;

EID: 62549090133     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molimm.2008.11.018     Document Type: Article

References (68)

1. Awdeh Z.L., and Alper C.A. Inherited structural polymorphism of the fourth component of human complement. Proc. Natl. Acad. Sci. U.S.A. 77 (1980) 3576-3580
2. Awdeh Z.L., Raum D., and Alper C.A. Genetic polymorphism of human complement C4 and detection of heterozygotes. Nature 282 (1979) 205-208
3. Awdeh Z.L., Raum D., Yunis E.J., and Alper C.A. Extended HLA/complement allele haplotypes: evidence for T/t-like complex in man. Proc. Natl. Acad. Sci. U.S.A. 80 (1983) 259
4. Bank R.A., Hettema E.H., Muijs M.A., Pals G., Arwert F., Boomsma D.I., and Pronk J.C. Variation in gene copy number and polymorphism of the human salivary amylase isoenzyme system in Caucasians. Hum. Genet. 89 (1992) 213-222
5. Berger S.P., Roos A., and Daha M.R. Complement and the kidney: what the nephrologist needs to know in 2006?. Nephrol. Dial. Transplant. 20 12 (2005) 2613-2619
6. Blanchong C.A., Zhou B., Rupert K.L., Chung E.K., Jones K.N., Sotos J.F., Rennebohm R.M., and Yu C.Y. Deficiencies of human complement component C4A and C4B and heterozygosity in length variants of RP-C4-CYP21-TNX (RCCX) modules in Caucasians: the load of RCCX genetic diversity on MHC-associated disease. J. Exp. Med. 191 (2000) 2183-2196
7. Bohmig G.A., Bartel G., and Wahrmann M. Antibodies, isotypes and complement in allograft rejection. Curr. Opin. Organ. Transplant. 13 (2008) 411-418
8. Burch G.H., Gong Y., Liu W., Dettman R., Curry C.J., Smith L., Miller W.L., and Bristow J. Tenascin-X deficiency is associated with Ehlers-Danlos syndrome. Nat. Genet. 17 (1997) 104-108
9. Carroll M.C. A protective role for innate immunity in systemic lupus erythematosus. Nat. Rev. Immunol. 4 (2004) 825-831
10. Carroll M.C., Campbell R.D., Bentley D.R., and Porter R.R. A molecular map of the human major histocompatibility complex class III region linking complement genes C4, C2 and factor B. Nature 307 (1984) 237-241
11. Carroll M.C., Campbell R.D., and Porter R.R. Mapping of steriod 21-hydroxylase genes adjacent to complement C4 genes in HLA, the major histocompatibility complex in man. Proc. Natl. Acad. Sci. U.S.A. 82 (1985) 521-525
12. Carroll M.C., Palsdottir A., Belt K.T., and Porter R.R. Deletion of complement C4 and steroid 21-hydroxylase genes in the HLA class III region. EMBO J. 4 (1985) 2547-2552
13. Chu X., Rittner C., and Schneider P.M. Length polymorphism of the human complement component C4 gene is due to an ancient retroviral integration. Exp. Clin. Immunogenet. 12 (1995) 74-81
14. Chung E.K., Wu Y.L., Yang Y., Zhou B., and Yu C.Y. Human complement components C4A and C4B genetic diversities: complex genotypes and phenotypes. In: Coligan J.E., Bierer B.E., Margulis D.H., Shevach E.M., and Strober W. (Eds). Current Protocols in Immunology (2005), John Wiley & Sons, Inc., Edison, NJ 13.8.1-13.8.36
15. Chung E.K., Yang Y., Rennebohm R.M., Lokki M.L., Higgins G.C., Jones K.N., Zhou B., Blanchong C.A., and Yu C.Y. Genetic sophistication of human complement C4A and C4B and RP-C4-CYP21-TNX (RCCX) modules in the major histocompatibility complex (MHC). Am. J. Hum. Genet. 71 (2002) 823-837
16. Chung E.K., Yang Y., Rupert K.L., Jones K.N., Rennebohm R.M., Blanchong C.A., and Yu C.Y. Determining the one, two, three or four long and short loci of human complement C4 in a major histocompatibility complex haplotype encoding for C4A or C4B proteins. Am. J. Hum. Genet. 71 (2002) 810-822
17. Cornacoff J.B., Hebert L.A., Smead W.L., VanAman M.E., Birmingham D.J., and Waxman F.J. Primate erythrocyte-immune complex-clearing mechanism. J. Clin. Invest. 71 (1983) 236-247
18. Dangel A.W., Mendoza A.R., Baker B.J., Daniel C.M., Carroll M.C., Wu L.-C., and Yu C.Y. The dichotomous size variation of human complement C4 gene is mediated by a novel family of endogenous retroviruses which also establishes species-specific genomic patterns among Old World primates. Immunogenetics 40 (1994) 425-436
19. Dawkins R., Leelayuwat C., Gaudieri S., Tay G., Hui J., Cattley S., Martinez P., and Kulski J. Genomics of the major histocompatibility complex: haplotypes, duplication, retroviruses and disease. Immunol. Rev. 167 (1999) 275-304
20. Feucht H.E. Complement C4d in graft capillaries-the missing link in the recognition of humoral alloreactivity. Am. J Transplant. 3 (2003) 646-652
21. Feucht H.E., and Mihatsch M.J. Diagnostic value of C4d in renal biopsies. Curr. Opin. Nephrol. Hypertens. 14 (2005) 592-598
22. Giles C.M., Uring-Lambert B., Goetz J., Hauptmann G., Fielder A.H.L., Ollier W., Rittner C., and Robson T. Antigenic determinants expressed by human C4 allotypes: a study of 325 families provides evidence for the structural antigenic model. Immunogenetics 27 (1988) 442-448
23. Gitelman S.E., Bristow J., and Miller W.L. Mechanism and consequences of the duplication of the human C4/P450c21/gene X locus. Mol. Cell. Biol. 12 (1992) 2124-2134
24. Goncalves J., Friaes A., and Moura L. Congenital adrenal hyperplasia: focus on the molecular basis of 21-hydroxylase deficiency. Expert. Rev. Mol. Med. 9 (2007) 1-23
25. Higashi Y., Yoshioka H., Yamane M., Gotoh O., and Fujii-Kuriyama Y. Complete nucleotide sequence of two steroid 21-hydroxylase genes tandemly arranged in human chromosome: a pseudogene and a genuine gene. Proc. Natl. Acad. Sci. U.S.A. 83 (1986) 2841-2845
26. Horton R., Gibson R., Coggill P., Miretti M., Allcock R.J., Almeida J., Forbes S., Gilbert J.G., Halls K., Harrow J.L., Hart E., Howe K., Jackson D.K., Palmer S., Roberts A.N., Sims S., Stewart C.A., Traherne J.A., Trevanion S., Wilming L., Rogers J., de Jong P.J., Elliott J.F., Sawcer S., Todd J.A., Trowsdale J., and Beck S. Variation analysis and gene annotation of eight MHC haplotypes: the MHC Haplotype Project. Immunogenetics 60 (2008) 1-18
27. Kato A., Endo T., Abiko S., Ariga H., and Matsumoto K. Induction of truncated form of tenascin-X (XB-S) through dissociation of HDAC1 from SP-1/HDAC1 complex in response to hypoxic conditions. Exp. Cell Res. 314 (2008) 2661-2673
28. a, reacting with a red cell or serum antigen. Vox Sang. 30 (1976) 175-180
29. Lupski J.R. Structural variation in the human genome. N. Engl. J. Med. 356 (2007) 1169-1171
30. Malaviya A.N., Singh R.R., Singh Y.N., Kapoor S.K., and Kumar A. Prevalence of systemic lupus erythematosus in India. Lupus 2 (1993) 115-118
31. Mauff G., Alper C.A., Awdeh Z., Batchelor J.R., Bertrams T., Bruun-Petersen G., Dawkins R.L., Demant P., Edwards J., Grosee-Wilde H., Hauptmann G., Klouda P., lamn L., Mollenhauer E., Nerl C., Olaisen B., O'Neill G., Rittner C., Ross M.H., Skanes V., Teisberg N., and Wells L. Statement on the nomenclature of human C4 allotypes. Immunobiology 164 (1983) 184-191
32. McCarroll S.A. Extending genome-wide association studies to copy-number variation. Hum. Mol. Genet. 17 (2008) R135-R142
33. Middleton J., and Crooksten M. Chido substance in plasma. Vox Sang. 23 (1972) 256-261
34. New M.I. Extensive clinical experience: nonclassical 21-hydroxylase deficiency. J. Clin. Endocrinol. Metab. 91 (2006) 4205-4214
35. O'Neill G.J., Yang S.Y., and DuPont B. Two HLA-linked loci controlling the fourth component of human complement. Proc. Natl. Acad. Sci. U.S.A. 75 (1978) 5165-5169
36. Pang S.Y., Wallace M.A., Hofman L., Thuline H.C., Dorche C., Lyon I.C., Dobbins R.H., Kling S., Fujieda K., and Suwa S. Worldwide experience in newborn screening for classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Pediatrics 81 (1988) 866-874
37. Papiha S.S. Genetic variation in India. Hum. Biol. 68 (1996) 607-628
38. Perry G.H., Dominy N.J., Claw K.G., Lee A.S., Fiegler H., Redon R., Werner J., Villanea F.A., Mountain J.L., Misra R., Carter N.P., Lee C., and Stone A.C. Diet and the evolution of human amylase gene copy number variation. Nat. Genet. 39 (2007) 1256-1260
39. Rama Devi A.R., and Naushad S.M. Newborn screening in India. Indian J. Pediatr. 71 (2004) 157-160
40. Ranjan P., Nada R., Jha V., Sakhuja V., and Joshi K. The role of C4d immunostaining in the evaluation of the causes of renal allograft dysfunction. Nephrol. Dial. Transplant. 23 (2008) 1735-1741
41. Redon R., Ishikawa S., Fitch K.R., Feuk L., Perry G.H., Andrews T.D., Fiegler H., Shapero M.H., Carson A.R., Chen W., Cho E.K., Dallaire S., Freeman J.L., Gonzalez J.R., Gratacos M., Huang J., Kalaitzopoulos D., Komura D., MacDonald J.R., Marshall C.R., Mei R., Montgomery L., Nishimura K., Okamura K., Shen F., Somerville M.J., Tchinda J., Valsesia A., Woodwark C., Yang F., Zhang J., Zerjal T., Zhang J., Armengol L., Conrad D.F., Estivill X., Tyler-Smith C., Carter N.P., Aburatani H., Lee C., Jones K.W., Scherer S.W., and Hurles M.E. Global variation in copy number in the human genome. Nature 444 7118 (2006) 444-454
42. Robson T., Heard R.N.S., and Giles C.M. An epitope on the C4 β light (L) chains detected by human anti-Rg; its relationship with β-chain polymorphism and MHC associations. Immunogenetics 30 (1989) 344-349
43. Rodrigues N.R., Dunham I., Yu C.Y., Carroll M.C., Porter R.R., and Campbell R.D. Molecular characterization of the HLA-linked steroid 21-hydroxylase B gene from an individual with congenital adrenal hyperplasia. EMBO J. 6 (1987) 1653-1661
44. Roos M.H., Mollenhauer E., Demant P., and Rittner C. A molecular basis for the two locus model of human complement component C4. Nature 298 (1982) 854-855
45. Rupert K.L., Rennebohm R.M., and Yu C.Y. An unequal crossover between the RCCX modules of the human MHC leading to the presence of a CYP21B gene and a tenascin TNXB/TNXA-RP2 recombinant between C4A and C4B genes in a patient with juvenile rheumatoid arthritis. Exp. Clin. Immunogenet. 16 (1999) 81-97
46. Rus v., Maury E.E., and Hochberg M.C. The epidemilogy of systemic lupus erythematosus. In: Wallace D.J., and Hahn B.H. (Eds). Dubois' Lupus Erythematosus (2007), Lippincott Williams & Wilkins, Philadelphia 34-44
47. Sebat J., Lakshmi B., Troge J., Alexander J., Young J., Lundin P., Maner S., Massa H., Walker M., Chi M., Navin N., Lucito R., Healy J., Hicks J., Ye K., Reiner A., Gilliam T.C., Trask B., Patterson N., Zetterberg A., and Wigler M. Large-scale copy number polymorphism in the human genome. Science 305 (2004) 525-528
48. Seelen M.A.J., Brooimans R.A., van der Dorp F.J., van Es L.A., and Daha M.R. Interferon-γ mediates stimulation of complement C4 biosynthesis in human proximal tubular epithelial cells. Kidney Int. 44 (1993) 50-57
49. Shen L.M., Wu L.C., Sanlioglu S., Chen R., Mendoza A.R., Dangel A., Carroll M.C., Zipf W., and Yu C.Y. Structure and genetics of the partially duplicated gene RP located immediately upstream of the complement C4A and C4B genes in the HLA class III region: molecular cloning, exon-intron structure, composite retroposon and breakpoint of gene duplication. J. Biol. Chem. 269 (1994) 8466-8476
50. Sim E., and Cross S. Phenotyping of human complement component C4, a class III HLA antigen. Biochem. J. 239 (1986) 763-767
51. Stewart C.A., Horton R., Allcock R.J., Ashurst J.L., Atrazhev A.M., Coggill P., Dunham I., Forbes S., Halls K., Howson J.M., Humphray S.J., Hunt S., Mungall A.J., Osoegawa K., Palmer S., Roberts A.N., Rogers J., Sims S., Wang Y., Wilming L.G., Elliott J.F., de Jong P.J., Sawcer S., Todd J.A., Trowsdale J., and Beck S. Complete MHC haplotype sequencing for common disease gene mapping. Genome Res. 14 (2004) 1176-1187
52. Tee M.K., Thomson A.A., Bristow J., and Miller W.L. Sequences promoting the transcription of the human XA gene overlapping P450c21A correctly predict the presence of a novel, adrenal-specific, truncated form of tenascin-X. Genomics 28 (1995) 171-178
53. Teisberg P., Akesson I., Olaisen B., Gedde-Dahl, and Thorsby E. Genetic polymorphism of C4 in man and localisation of a structural C4 locus to the HLA gene complex of chromosome 6. Nature 264 (1976) 253-254
54. Walport M.J. Complement-part I. N. Engl. J. Med. 344 (2001) 1058-1066
55. White P.C., New M.I., and DuPont B. HLA-linked congenital adrenal hyperplasia results from a defective gene encoding a cytochrome P-450 specific for steroid 21-hydroxylation. Proc. Natl. Acad. Sci. U.S.A. 81 (1984) 7505-7509
56. White P.C., and Speiser P.W. Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. Endocr. Rev. 21 (2000) 245-291
57. Wilson R.C., Nimkarn S., Dumic M., Obeid J., Azar M.R., Najmabadi H., Saffari F., and New M.I. Ethnic-specific distribution of mutations in 716 patients with congenital adrenal hyperplasia owing to 21-hydroxylase deficiency. Mol. Genet. Metab. 90 (2007) 414-421
58. Wu Y.L., Savelli S.L., Yang Y., Zhou B., Rovin B.H., Birmingham D.J., Nagaraja H.N., Hebert L.A., and Yu C.Y. Sensitive and specific real-time PCR Assays to accurately determine copy-number variations (CNVs) of human complement C4A, C4B, C4-Long, C4-Short and RCCX modules: elucidation of C4 CNVs in 50 consanguineous subjects with defined HLA genotypes. J. Immunol. 179 (2007) 3012-3025
59. Yang Y., Chung E.K., Wu Y.L., Savelli S.L., Nagaraja H.N., Zhou B., Hebert M., Jones K.N., Shu Y., Kitzmiller K., Blanchong C.A., McBride K., Higgins G.C., Rennebohm R.M., Rice R.R., Hackshaw K.V., Roubey R.A., Grossman J.M., Tsao B.P., Birmingham D.J., Rovin B.H., Hebert L.A., and Yu C.Y. Gene copy number variation and associated polymorphisms of complement component C4 in human systemic erythematosus (SLE): low copy number is a risk factor for and high copy number is a protective factor against European American SLE disease susceptibility. Am. J. Hum. Genet. 80 (2007) 1037-1054
60. Yang Y., Chung E.K., Zhou B., Blanchong C.A., Yu C.Y., Füst G., Kovács M., Vatay A., Szalai C., Karádi I., and Varga L. Diversity in intrinsic strengths of the human complement system: serum C4 protein concentrations correlate with C4 gene size and polygenic variations, hemolytic activities and body mass index. J. Immunol. 171 (2003) 2734-2745
61. Yang Z., Mendoza A.R., Welch T.R., Zipf W.B., and Yu C.Y. Modular variations of HLA class III genes for serine/threonine kinase RP, complement C4, steroid 21-hydroxylase CYP21 and tenascin TNX (RCCX): a mechanism for gene deletions and disease associations. J. Biol. Chem. 274 (1999) 12147-12156
62. Yu C.Y. The complete exon-intron structure of a human complement component C4A gene: DNA sequences, polymorphism, and linkage to the 21-hydroxylase gene. J. Immunol. 146 (1991) 1057-1066
63. Yu C.Y., Belt K.T., Giles C.M., Campbell R.D., and Porter R.R. Structural basis of the polymorphism of human complement component C4A and C4B: gene size, reactivity and antigenicity. EMBO J. 5 (1986) 2873-2881
64. Yu C.Y., and Campbell R.D. Definitive RFLPs to distinguish between the human complement C4A/C4B isotypes and the major Rodgers/Chido determinants: application to the study of C4 null alleles. Immunogenetics 25 (1987) 383-390
65. Yu C.Y., Campbell R.D., and Porter R.R. A structural model for the location of the Rodgers and the Chido antigenic determinants and their correlation with the human complement C4A/C4B isotypes. Immunogenetics 27 (1988) 399-405
66. Yu C.Y., Chung E.K., Yang Y., Blanchong C.A., Jacobsen N., Saxena K., Yang Z., Miller W., Varga L., and Fust G. Dancing with complement C4 and the RP-C4-CYP21-TNX (RCCX) modules of the major histocompatibility complex. Progr. Nucl. Acid Res. Mol. Biol. 75 (2003) 217-292
67. Yu C.Y., Hauptmann G., Yang Y., Wu Y.L., Birmingham D.J., Rovin B.H., and Hebert L.A. Complement deficiencies in human systemic lupus erythematosus (SLE) and SLE nephritis: epidemiology and pathogenesis. In: Tsokos G.C. (Ed). Systemic Lupus Erythematosus: A Companion to Rheumatology (2007), Elsevier, Philadelphia 203-213
68. Yu C.Y., Yang Z., Blanchong C.A., and Miller W. The human and mouse MHC class III region: a parade of the centromeric segment with 21 genes. Immunol. Today 21 (2000) 320-328